November Recall Roundup: Tablets Didn’t Melt in J&J’s Hands
This article was originally published in The Gold Sheet
Johnson & Johnson’s drug manufacturing woes continued to generate recalls in November.
You may also be interested in...
US HHS turns to COVID-19 vaccine distributor to assemble vaccine administration kits, citing revised vaccine delivery schedule.
Stand-alone bill headed for Senate, where it fared poorly in coronavirus response legislative packages.
Agency begins gathering manufacturing plant data to prepare for disruptions that can drain inventories over a weekend.